Genmab A/S (GMAB) FY2025Q1 Earning Prediction
Genmab A/S (GMAB) is set to release its earnings performance on 05/08 ET in Pre-Market trading. Consensus forecasts predict a revenue of 5.02B and an earnings per share (EPS) of 0.23 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
GMAB Transcript
The earnings call highlights strong financial performance, increased revenue and profit guidance, and positive sales momentum for key products. Despite some concerns about specific trial terminations and unclear responses, the overall sentiment remains positive due to optimistic management outlook, strategic product positioning, and upcoming regulatory milestones. The raised guidance and strong product pipeline further support a positive stock price movement.
GMAB Slides
GMAB Report
Frequently Asked Questions
What is the Genmab A/S FY2025Q1 Earnings Release Date and Time?
Genmab A/S (GMAB) is scheduled to release its FY2025Q1 earnings report onMay 8, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Genmab A/S FY2025Q1 Revenue and EPS?
Analysts' consensus predicts 5.02B in revenue and an EPS of 0.23 for Genmab A/S's FY2025Q1.
What Does Intellectia's AI Predict for Genmab A/S FY2025Q1 Earnings?
Intellectia's exclusive AI algorithms forecast a forGenmab A/S's FY2025Q1 earnings, with a prediction date of May 8, 2025. Genmab A/S
How Can I Use This Earnings Prediction to Trade GMAB Stock?
Leverage Intellectia's AI forecast to position trades ahead of theMay 8, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Genmab A/S FY2025Q1?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
